Found 58 matching trials
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
EARLY_PHASE1The main objective of this study is to observe and evaluate the safety and ...
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies
PHASE1The study is being conducted to evaluate the Safety, Tolerability, Pharmaco...
Location
Multiple Locations
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
PHASE1This is a Phase 1, open-label, dose escalation study in patients with advan...
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
PHASE2This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Location
Cancer Center of Guangzhou Medical University
Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial
PHASE3This study is a prospective, multicenter, multi-cohort Phase III clinical t...
Location
Multiple Locations
Phase โ
/โ
ก Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
PHASE1This is an open-label, single-arm, dose-escalation, and dose-expansion clin...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
PHASE1This study is an open-label, dose-escalation and expansion, Phase I clinica...
Status
Active Not Recruiting
Location
St Vincent's Hospital Sydney
Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors
PHASE1A Phase I/II, Open-Label, Multiple Centre Clinical Study to Evaluate the Sa...
A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors
PHASE1A Phase I/II, Open-Label, Dose-Escalation and Dose-Expansion Clinical Study...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma
PHASE2The goal of this clinical trial is to evaluate the efficacy and safety of n...
Location
Multiple Locations